Please assess the completion status of the following clinical trial:

Trial Title: Effect of Artemisia Dracunculus on Glucose Intolerance, Insulin Sensitivity and Insulin Secretion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients both sexes~* Age between 30 and 60 years~* Glucose intolerance according ADA criteria (blood glucose leve ≥140 mg/dl and ≤199 mg/dL after an oral glucose tolerance test with 75 of oral glucose~* Informed consent signed~Exclusion Criteria:~* Women with confirmed or suspected pregnancy~* Women under lactation and/or puerperium~* Hypersensibility to Artemisia dracunculus~* Physical impossibility for taking pills~* Known uncontrolled renal, hepatic, heart or thyroid disease~* Previous treatment for glucose~* Diabetes diagnosis~* BMI ≥39.9 kg/m2

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Artemisia Dracunculus (Type: EXPERIMENTAL): Artemisia Dracunculus extract, 2 capsules of 500 mg, two times per day before breakfast and dinner during 90 days
- Placebo (Type: PLACEBO_COMPARATOR): Calcined magnesia, 2 capsules of 500 mg, two times per day before breakfast and dinner during 90 days

Based on this trial design, predict the completion outcome and termination type (if applicable).